Injections of the neuroprotective peptide NAP to newborn mice attenuate head-injury-related dysfunction in adults

NeuroReport

Volumn 14, Issue 3, 2003, Pages 481-484

  Zaltzman, Roy ^a   Beni, Sara M ^b   Giladi, Eliezer ^a   Pinhasov, Albert ^a   Steingart, Ruth A ^a   Romano, Jacob ^a   Shohami, Esther ^b   Gozes, Illana ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

Inflammation; Peptides; Traumatic brain injury; Water maze

Indexed keywords

CD11B ANTIGEN; MESSENGER RNA; PEPTIDE; PROTEIN NAP; UNCLASSIFIED DRUG;

ALERTNESS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEAD INJURY; MALE; MAZE TEST; MOTOR PERFORMANCE; MOUSE; NERVE DEGENERATION; NEUROLOGIC DISEASE; NEUROPROTECTION; NEWBORN; NONHUMAN; PERFORMANCE; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN EXPRESSION;

EID: 0344837696     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200303030-00037     Document Type: Article

References (25)

1. Gozes I and Brenneman DE. J Mol Neurosci 14, 61-64 (2000).
2. Zamostiano R, Pinhasov A, Gelber E et al. J Biol Chem 276, 708-714 (2001).
3. Bassan M, Zamostiano R, Davidson A et al. J Neurochem 72, 1283-1293 (1999).
4. Zemlyak I, Furman S, Brenneman DE et al. Reg Pept 96, 39-43 (2000).
5. Offen D, Sherki Y, Melamed E et al. Brain Res 854, 257-262 (2000).
6. Steingart RA, Solomon B, Brenneman DE et al. J Mol Neurosci 15, 137-145 (2000).
7. Sigalov E, Fridkin M, Brenneman DE et al. J Mol Neurosci 15, 147-154 (2000).
8. Beni-Adani L, Gozes I, Cohen Y et al. J Pharmacol Exp Ther 296, 57-63 (2001).
9. Spong CY, Abebe DT, Gozes I et al. J Pharmacol Exp Ther 297, 774-779 (2001).
10. Leker RR, Teichner A, Grigoriadis N et al. Stroke 33, 1085-1092 (2002).
11. Romano J, Beni-Adani L, Nissenbaum OL et al. J Mol Neurosci 18, 37-45 (2002).
12. Panikashvili D, Simeonidou C, Ben-Shabat S et al. Nature 423, 527-531 (2001).
13. Gordon I, Grauer E, Genis I et al. Neurosci Lett 199, 1-4 (1995).
14. Gozes I. Trends Neurosci 24, 700-705 (2001).
15. Hill JM, Gozes I, Hill JL et al. Peptides 12, 187-192 (1991).
16. Gozes I, Bachar M, Bardea A et al. J Neurobiol 33, 329-342 (1997).
17. Gozes I, Giladi E, Pinhasov A et al. J Pharmacol Exp Therap 293, 1191-1198 (2000).
18. Gonzales-Scarano F and Baltuch G. Annu Rev Neurosci 22, 219-240 (1999).
19. Tan SM, Hyland RH, Al-Shamkhani A et al. J Immunol 165, 2574-2581 (2000).
20. Benimetskaya L, Loike JD, Khaled Z et al. Nature Med 3, 414-420 (1997).
21. Koshinaga M, Katayama Y, Fukushima M et al. J Neurotrauma 17, 185-192 (2000).
22. Hailer NP, Glomsda B and Blaheta RA. Neurosci Lett 298, 33-36 (2001).
23. Colicos MA and Dash PK. Brain Res 739, 120-131 (1996).
24. Clark RS, Kochanek PM, Watkins SC et al. J Neurochem 74, 740-753 (2000).
25. Chopp M, Li Y, Jiang N, Zhang RL et al. J Cerebr Blood Flow Metab 16, 578-584 (1996).